Cannabis Law Report

JULY 2, 2021

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

MMJ Recs

JANUARY 6, 2024

From tinctures and edibles to topicals and inhalables, the variety of options can be overwhelming. Topicals , in the form of creams, balms, or patches, target localized pain or inflammation without inducing psychoactive effects. Capsules and pills provide a familiar oral ingestion method, akin to traditional pharmaceuticals.

Chronic Pain 52

Chronic Pain Topical Marijuana Indica 52

Cannabis Law Report

SEPTEMBER 6, 2021

GW Pharmaceuticals. GW Pharmaceuticals. Key Topics Covered: 1 Preface. Key Topics Covered: 1 Preface. Looking forward, the publisher expects the global medical cannabis market to grow at a CAGR of 15.3% during 2021-2026. Companies Mentioned. Canopy Growth Corporation. Aurora Cannabis Inc. Aphria Inc. Companies Mentioned.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Cannabis Law Report

JULY 9, 2021

Oftentimes people choose to use CBD oils that can be taken orally or applied topically, however, when regularly buying CBD oils the cost can soon add up so some people choose to check out this page to get discounts and advice on the most suitable CBD products for them. Alleviation of Neurological Problems. Relief from Symptoms of Cancer.

Blood Pressure 105

Blood Pressure CBD Pets Oil 105

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

For example, many anti-anxiety pharmaceuticals are habit-forming, entail significant negative side effects, and can also cause physical problems such as diminished mobility or coordination. CBD is also available in conventional pill and tablet form, as a base to use for cooking, and in topical products. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Canna Law Blog

APRIL 27, 2020

Some related topics we’ve written on are CBD comestibles , CBD pet products , CBD in alcohol , and CBD topicals. We’ve also written about the enforcement actions issued by the FDA to CBD companies, including those issued to CBD companies selling topical products, and on April 23, 2020, the FDA announced its latest round of enforcement.

CBD 59

CBD Topical Oil Treatment 59

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Epidiolex has received FDA approval to treat Dravet Syndrome and Lennox-Gestaut Syndrome; two very rare forms of epilepsy that manifest in early childhood.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

CannaTech

JANUARY 16, 2019

Pharmaceutical grade cannabis is relatively new in parts of the world. This statistic accounts for medicines treating patients with epilepsy, anxiety, depression, chronic pain, and other illnesses. This article has primarily offered a small dose of the pharmaceutical side of the medical cannabis market in Latin America.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. For instance, as of June 2021, InMed Pharmaceuticals, Inc., Key Topics Covered: Chapter 1 Methodology and Scope. Market Segmentation and Scope.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Leaf Science

JULY 23, 2019

In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex. We shall look into what these benefits may be and what the science do we have that backs this up.

Strains 74

Strains Cannabinoids Epilepsy THC 74

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Cannigma

MARCH 7, 2022

When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone. Those recruited will apply either CBN cream or placebo to non-wounded areas over a course of 28 days.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

OCTOBER 20, 2019

She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. xi] “Pharmaceutical Research and Manufacturers of America (PhRMA) spent $19.7 as a Schedule II substance.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Cannabis Law Report

SEPTEMBER 28, 2021

Topical Creams. CBD oil and other products containing this cannabinoid are used to treat a number of health conditions, including chronic pain, inflammation, mood disorders, epilepsy, osteoporosis, and diabetes. Acupressure is an alternative method to treat pain without using pharmaceuticals. CBD Products. Acupressure.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52

Cannabis Law Report

FEBRUARY 3, 2022

The presence of major key players, pharmaceutical and biotechnology industries worldwide, and their experimental approach drives the cannabis market growth. Based on route of administration, the market is segmented into oral, topical, inhalation, rectal, sublingual. Gw Pharmaceuticals plc. Medical Marijuana Inc. Cv Sciences Inc.

Indica 52

Indica Oil Legalization Research and Development 52

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. Source: The Guardian ). Source: SIPSE.COM ). t be denied.

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Cannabis Law Report

JUNE 20, 2019

But, some patients often use pharmaceutical drugs to reduce symptoms of stress, depression, and anxiety. Multiple sclerosis and epilepsy. Some of them include Alzheimer’s disease, Parkinson’s disease, cancer, glaucoma, multiple sclerosis, epilepsy, anorexia, insomnia, and post-traumatic stress disorder, among others.

History 67

History Medicine Chronic Pain Conditions 67

PrestoDoctor

OCTOBER 13, 2023

However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug. While cannabis is still a controversial topic, Marinol has been approved by the FDA for specific medical uses. Medical cannabis consumption has various methods , including smoking, vaping, edibles, oils, and topicals.

THC 98

THC Chronic Pain Treatment Conditions 98

Alchimia

JUNE 20, 2016

That could explain why kids using CBD to treat epilepsy may experience some of the side effects of THC, like sleepiness. Topical application is particularly efficient to treat localized pains or skin problems like acne or psoriasis. CBD crystals , 98% purity. Cannabidiol can also be used via CBD creams, ointments and other compounds.

Medicine 76

Medicine CBD Research and Development Epilepsy 76

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52

WeedAdvisor

JANUARY 8, 2019

Even if trials were successful, it is safe to say that using marijuana to treat cancer would meet resistance from the pharmaceutical companies and medical communities alike. While research into the topic is rare, it is not non-existent. This is unfortunate, as 9.6 The Endocannabinoid System in Cannabis Cancer Treatment. Final Thoughts.

Treatment 75

Treatment Research and Development Cannabinoids THC 75

SpeedWeed

JULY 29, 2021

This scientific study found that THCV works in a similar way to pharmaceutical anti-obesity drugs with far less risk of side effects. It may therefore offer a restful night’s sleep without the grogginess or hung-over feeling that pharmaceutical sedatives or even melatonin can produce in some instances. .

Sleep 52

Sleep Cannabinoids Oil THC 52

Cannabis Law Report

SEPTEMBER 8, 2019

Of course, the real near-term excitement revolves around the upcoming launch of derivative products (e.g,, edibles, vapes, topicals, concentrates, and infused beverages) by mid-December. can be partially attributed to the success of GW Pharmaceuticals ( NASDAQ:GWPH ) , the cannabinoid-based drug developer that had the U.S.

Pharmaceutical 45

Pharmaceutical Recreational Patients Hash 45

Weedistry

MARCH 9, 2019

Both CBD and THC (another cannabinoid that is found in large quantities) have incredible effects on the body that rival even the most well-recognized and powerful pharmaceuticals on the market. CBD is found in big quantities in the cannabis plant. Over the last few years, the popularity of CBD has expanded dramatically.

CBD 40

CBD Epilepsy Treatment Chronic Pain 40

The Joint Blog

SEPTEMBER 17, 2020

This is especially exciting for epilepsy patients who suffer from these problems on a regular basis. It is mainly used to treat two rare forms of epilepsy that are very difficult to treat with other methods. Either way, many people will attest to the effectiveness of CBD-based topical treatments.

Oil 26

Oil CBD Blood Pressure Research and Development 26

Cannabis Law Report

JANUARY 24, 2022

Key Topics Covered: Chapter 1 Methodology and Scope. GW Pharmaceuticals, plc. Chapter 2 Executive Summary. Chapter 3 North America Legal Cannabis Market: Variables, Trends & Scope. Market Segmentation. Penetration & Growth Prospect Mapping. Market Dynamics. Market Driver Analysis. Market Restraint Analysis. Recreational Use.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. About Virpax Pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

JANUARY 4, 2022

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. BERWYN, Pa.–(BUSINESS For more information, please visit www.virpaxpharma.com. Wainwright & Co.

Pharmaceutical 52

Pharmaceutical Research and Development Chronic Pain Events 52

Cannabis Law Report

SEPTEMBER 20, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. About Virpax Pharmaceuticals.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

DECEMBER 28, 2021

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Epilepsy Behav. Accessed October 17, 2022. 2021.108514.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

SEPTEMBER 12, 2022

Extracts derived from hemp plants are infused into a variety of products, both ingestible and topical, to produce therapeutic effects, sometimes without the side effects of synthetic pharmaceutical drugs. The FDA also asserted that CBD was considered a drug because FDA had approved Epidiolex, a marijuana derived CBD drug for epilepsy.

Hemp 52

Hemp CBD Food Extraction 52

Cannabis Law Report

MARCH 3, 2020

Courtney Parker, Pensacola Store Manager amplifies this goal: “At MÜV our main priority is to combine pharmaceutical industry precision with an engaging and compassionate patient experience. Florida’s medical marijuana law allows for cannabis to be used as an edible, oil, topical, vaporized or smoked. FLORIDA FOCUS.

Dispensary 64

Dispensary Patients Cannabis Wellness and Beauty 64

Green Relief

FEBRUARY 20, 2018

I was first introduced to the topic of Epigenetics in 2008 at a business conference in Florida, and as a medical professional I was immediately intrigued. 10/8/2017. 0 COMMENTS. By Janna Champagne, BSN, RN. This supports what we’ve known for a long time: that given what it needs, the body can balance and heal itself.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Cannabis Law Report

JANUARY 18, 2022

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Well-tolerated with No Serious Adverse Findings. BERWYN, Pa.–(BUSINESS Mack, Chairman and CEO of Virpax.

Safety 52

Safety Chronic Pain Research and Development Pharmaceutical 52

Cannabis Law Report

DECEMBER 20, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. First Patient Expected to be Enrolled by Q2 of 2022. Data To Support Regulatory Filings in the United States.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

OCTOBER 1, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Additionally, a video webcast of the presentation will be available beginning October 7, 2021 on the Investors section of the Virpax Pharmaceuticals website at [link]. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52